Summary
Norfolk Southern Corporation (NSC) filed an 8-K on July 26, 2011, primarily to announce two key corporate governance changes. The Board of Directors elected Robert Bradway as a new director, effective July 25, 2011, and appointed him to the Finance and Audit Committees. Mr. Bradway brings significant financial and operational experience from his roles at Amgen and Morgan Stanley, which could be valuable to the company's strategic oversight. In addition, the Board amended the company's Bylaws to increase the size of the Board from 11 to 12 directors, effective immediately. This increase coincides with Mr. Bradway's appointment, suggesting a strategic decision to expand the board's capacity and potentially diversify its expertise. Investors should note these changes as they can influence future strategic decisions and board oversight.
Key Highlights
- 1Robert Bradway was elected as a new director to the Board of Directors, effective July 25, 2011.
- 2Mr. Bradway was appointed to serve on both the Finance and Audit Committees of the Board.
- 3Mr. Bradway brings prior experience as President and COO of Amgen, and as a Managing Director at Morgan Stanley.
- 4The company's Bylaws were amended to increase the total number of directors on the Board from 11 to 12.
- 5The increase in board size and Mr. Bradway's appointment are effective immediately as of July 25, 2011.
- 6Mr. Bradway received a grant of 3,000 restricted shares upon election, subject to a vesting period.